Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma

Abstract

Methyltransferase like 13 (METTL13), a kind of methyltransferase, is implicated in protein binding and synthesis. The upregulation of METTL13 has been reported in a variety of tumors. However, little was known about its potential function in head and neck squamous cell carcinoma (HNSCC) so far. In this study, we found that METTL13 was significantly upregulated in HNSCC at both mRNA and protein level. Increased METTL13 was negatively associated with clinical prognosis. And METTL13 markedly affected HNSCC cellular phenotypes in vivo and vitro. Further mechanism study revealed that METTL13 could regulate EMT signaling pathway by mediating enhancing translation efficiency of Snail, the key transcription factor in EMT, hence regulating the progression of EMT. Furthermore, Snail was verified to mediate METTL13-induced HNSCC cell malignant phenotypes. Altogether, our study had revealed the oncogenic role of METTL13 in HNSCC, and provided a potential therapeutic strategy.

References

[1] Torre LA, . Global cancer statistics, 2012. CA Cancer J. Clin., 2015, 65: 87.

[2] Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat. Rev. Cancer, 2011, 11: 9.

[3] Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin. Proc., 2016, 91: 386.

[4] Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol., 2019, 29: 212.

[5] Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell, 2009, 15: 195.

[6] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol., 2014, 15: 178.

[7] Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol., 2018, 13: 395.

[8] Zhou P, . The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol. Cancer, 2017, 16

[9] Lee SY, . Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol. Cancer, 2017, 16

[10] Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell, 2016, 166: 21.

[11] Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol., 2006, 7: 131.

[12] Sureban SM, . DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. PLoS ONE, 2013, 8: e73940.

[13] Leibovitch M, Topisirovic I. Dysregulation of mRNA translation and energy metabolism in cancer. Adv. Biol. Regul., 2018, 67: 30.

[14] Bhat M, . Targeting the translation machinery in cancer. Nat. Rev. Drug Discov., 2015, 14: 261.

[15] Ng TH, . Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer. BMC Cancer, 2019, 19

[16] Xu C, Hu DM, Zhu Q. eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation. Clin. Exp. Metastasis, 2013, 30: 933.

[17] Zhou D, . Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J. BIol. Chem., 2008, 283: 7064.

[18] Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl Acad. Sci. USA, 2004, 101: 11269.

[19] Liu S, . METTL13 methylation of eEF1A increases translational output to promote tumorigenesis. Cell, 2019, 176: 491.

[20] Jakobsson ME, . The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates. Nat. Commun., 2018, 9

[21] Wang Q, . METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut, 2020, 69: 1193.

[22] Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell, 2016, 62: 335.

[23] Jin D, . m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J. Hematol. Oncol., 2019, 12: 135.

[24] Sun T, . LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression. Oncogene, 2020, 39: 5358.

[25] Liang H, . miR-16 promotes the apoptosis of human cancer cells by targeting FEAT. BMC Cancer, 2015, 15

[26] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144: 646.

[27] Chen YC, . Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem. Biophys. Res. Commun., 2009, 385: 307.

[28] Pedersen MT, Jensen KB. Cell biology: unconventional translation in cancer. Nature, 2017, 541: 471.

[29] Lindqvist LM, Tandoc K, Topisirovic I, Furic L. Cross-talk between protein synthesis, energy metabolism and autophagy in cancer. Curr. Opin. Genet. Dev., 2018, 48: 104.

[30] Talavera A, . Phosphorylation decelerates conformational dynamics in bacterial translation elongation factors. Sci. Adv., 2018, 4: p9714.

[31] Hamey JJ, Wilkins MR. Methylation of elongation factor 1A: where, who, and why?. Trends Biochem. Sci., 2018, 43: 211.

[32] Arguelles S, Munoz MF, Cano M, Machado A, Ayala A. In vitro and in vivo protection by melatonin against the decline of elongation factor-2 caused by lipid peroxidation: preservation of protein synthesis. J. Pineal Res., 2012, 53: 1.

[33] Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb. Perspect. Biol., 2012, 4: a13706.

[34] Takahashi A, . A novel potent tumour promoter aberrantly overexpressed in most human cancers. Sci. Rep., 2011, 1

[35] Li L, . HN1L-mediated transcriptional axis AP-2gamma/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma. Cell Death Differ., 2019, 26: 2268.

[36] Miro C, . Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch. Nat. Commun., 2019, 10

[37] Wang WD, Shang Y, Li Y, Chen SZ. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation. Acta Pharmacol. Sin., 2019, 40: 1219.

[38] Wang X, . Bmi1 severs as a potential tumor-initiating cell marker and therapeutic target in esophageal squamous cell carcinoma. Stem Cells Int., 2020, 2020: 8877577.

[39] Lin X, . RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat. Commun., 2019, 10

[40] Chen D, . Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell, 2017, 20: 621.

Funding

Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(No.2018A030313610)

National Natural Science Foundation of China (National Science Foundation of China)(No.81872409)